AKT1 and central nervous system cancer: In an in vitro experiment, FEZF1 promoted the proliferation, migration, and invasion of glioma cells and inhibited cell apoptosis by activating the protein kinase B alpha (Akt)-extracellular signal-regulated kinase (ERK) pathway [30].